Yasir Y Elamin
15PUBLICATIONS
162CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (15)
Sort by Publication Date:
|Feb 19, 2026
Sustained Response to Lorlatinib and Pemetrexed in ALK Fusion-Positive Anaplastic Thyroid Carcinoma With Multiple Distant Metastases: A Case Report.Matheus Sewastjanow-Silva, Maria E Cabanillas, Eduardo Andreazza Dal Lago
|Dec 22, 2025
CRESTONE: A Phase II Study of the Efficacy and Safety of the HER3 Monoclonal Antibody, Seribantumab, in Solid Tumors With Neuregulin-1 (NRG1) Fusions.Tejas Patil, Jessica J Lin, Parneet K Cheema
|Sep 24, 2025
Poziotinib for EGFR exon 20-insertion NSCLC: Clinical efficacy of the phase 2 ZENITH trial and differential impact of EGFR exon 20 insertion location on sensitivity.Xiuning Le, Jacqulyne P Robichaux, Monique Nilsson
|Jul 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC.Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong
|Feb 27, 2025
Author Correction: CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
Pageof 3
Frequent Collaborators
12 joint publications
John V Heymach
9 joint publications
Don L Gibbons
9 joint publications
Xiuning Le
9 joint publications
Jianjun Zhang
7 joint publications
Tina Cascone
6 joint publications
J Jack Lee
5 joint publications
Natalie Vokes
5 joint publications
Marcelo V Negrao
5 joint publications
Jia Wu
4 joint publications
Justin F Gainor
